<DOC>
	<DOCNO>NCT01964495</DOCNO>
	<brief_summary>The purpose study evaluate two different treatment strategy patient admitted hospital Community Acquired Pneumonia . The investigator hypothesize treatment accord procalcitonin ( PCT ) C-reactive protein ( CRP ) effective reduce length antibiotic treatment .</brief_summary>
	<brief_title>Reduction Antibiotic Therapy Biomakers Patients With CAP Episodes ( REDUCE Study )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Male female patient diagnosis CAP criterion list : 1 . Age 18 , upper age limit employ . 2 . Patients must require hospitalisation . 3 . Clinical presentation acute illness one follow symptom : 1 . Temperature ≥ 38.0 ⁰C ( 100.4°F ) 2 . Dyspnoea 3 . Cough ( without expectoration sputum ) 4 . Chest pain 5 . Malaise fatigue 6 . Myalgia 7 . Gastrointestinal symptoms 8 . Rales , rhonchi wheeze 9 . Egophony bronchial breath sound 4 . New consolidation ( ) chest radiograph . 5 . Written inform consent obtain . 6 . ( Preevent ) Life expectancy &gt; 30 day Subjects present follow include study : 1 . ( Severe ) immunosuppression ( e.g . HIV infection , chemotherapy , use immunosuppressant ) . 2 . Active neoplastic disease . 3 . Obstruction pneumonia ( e.g . lung cancer ) . 4 . Aspiration pneumonia . 5 . Pneumonia develop within 8 day hospital discharge . 6 . Unable and/or unlikely comprehend and/or follow protocol . 7 . Pregnant and/or lactate woman . 8 . Other infection require treatment antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>